Hemodynamic Solutions that Transform Patient Care
Retia Medical is an innovative digital health company that develops accurate and affordable advanced hemodynamic solutions that confidently inform care protocols, improve outcomes and prevent complications for all high-risk patients.
The Argos® Cardiac Output (CO) Monitor enables advanced hemodynamic monitoring for high-risk patients. Its proprietary technology ensures patient safety with real-time, clinical decision support using advanced algorithms and allows clinicians to implement data-driven care protocols.
To support the company’s growth, Retia has built a strong team of industry-leading technical experts and clinician advisors.
Watch Video: The Retia Story
Marc Zemel, S.M., M.B.A.
Co-Founder and CEO
A serial entrepreneur and experienced leader at Fortune 500 companies and startups in the medical device, imaging, and capital equipment markets, Mr. Zemel has a long track record of raising capital and building high-performing teams to develop, launch and sell innovative new products. Prior to founding Retia, Mr. Zemel had several leadership roles in engineering, marketing and sales at a capital equipment startup and Becton Dickinson. He also authored 23 approved or pending patents. Mr. Zemel received his MS in Mechanical Engineering from the Massachusetts Institute of Technology and his MBA from the Yale School of Management.
Executive Vice President
Mr. Korten has extensive expertise in algorithm development and embedded engineering of patient monitoring and mobile health devices. As a member of the Executive Advisors Network for Columbia Technology Ventures, he works with entrepreneurs and inventors at Columbia University to facilitate the transfer of research innovations from the lab to the market, as well as supporting start-up efforts. He previously served as Chief Executive Officer of Versamed, which he sold to GE Healthcare. Mr. Korten received his MS in Bioengineering from the University of Michigan.
VP of Sales
James Ferreira has over 16 years of medical device sales and sales leadership experience. During that time, he has played an integral role in numerous commercial product launches and has expertise building and scaling commercial organizations. Mr. Ferreira is driven by his ability to build genuine connections with people at all levels, motivating sales teams to achieve consistently higher levels of success while creating relationships of trust and confidence with clients. Mr. Ferreira received his BS in Pharmaceutical Sciences from Massachusetts College of Pharmacy.
Roger Mecca, M.D.
Consultative Medical Officer
Dr. Mecca is a Clinical Professor of Anesthesiology at University of California, Irvine and has extensive expertise in critical care medicine, physiology, and perioperative care. He previously served as Vice President, Medical Affairs at Covidien Respiratory and Monitoring Solutions. Prior to that, he was Chairman, Department of Anesthesiology and Executive Director of Surgical Services at Danbury Health Systems. Dr. Mecca received his M.D. from New York Medical College and completed a residency in anesthesiology and a fellowship in critical care at Harvard Medical School.
Alexander Markovic, Ph.D.
Director, Software Engineering
Dr. Markovic brings over 20 years of experience in developing and designing software and has demonstrated expertise with product development lifecycles and streamlining engineering processes. Most recently he served as Senior Manager, Systems and Software Engineering at Bayer HealthCare Diabetes Care where he led software development for the connected glucose monitors, mobile apps and cloud-based systems. He received his M.Sc. and Ph.D. in Computer Engineering from the University of Belgrade.
Ramakrishna Mukkamala, Ph.D.
Dr. Mukkamala is a Co-Founder of Retia Medical and led the development of the MBA algorithm. He is a Professor of Bioengineering and Anesthesiology and Perioperative Medicine at the University of Pittsburgh. He is known for advancing hemodynamic monitoring by blood pressure waveform analysis and blood pressure measurement. He is an NIH-funded researcher and has been published in Science Translational Medicine, Scientific Reports (a Nature journal), IEEE Transactions on Biomedical Engineering, and American Journal of Physiology. He holds 15 issued and a number of pending patents. He received a Ph.D. degree in Electrical Engineering and Computer Science from the Massachusetts Institute of Technology and was a Post-Doctoral Fellow/Research Engineer in the Harvard-MIT Division of Health Sciences and Technology.
Retia is funded by the Pritzker-Vlock Family Office, which owns and manages a broad portfolio of public equities, consumer, biotech, industrial and medical equipment and technology businesses, several venture funds, and real estate. Karen Pritzker runs the PVFO and is involved in numerous national philanthropic efforts individually and through her family foundation with an emphasis on literacy, education, medicine, theater and land preservation.
Clinical Advisory Board →